New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
16:25 EDTPKIPerkinElmer rises over 4% after Verinata pact on prenatal test
PerkinElmer (PKI) traded up today after announcing a collaboration this morning with Verinata Health to expand access to the non-invasive prenatal test for Down syndrome and other chromosomal abnormalities. Under the terms of the collaboration agreement, PerkinElmer will serve as an exclusive Verinata Health commercial partner in the joint sales and marketing of the test in the United States. The collaboration consolidates and streamlines delivery of prenatal testing options due to the combination of PerkinElmer’s extensive prenatal testing menu with Verinata’s proprietary technologies for the early, non-invasive identification of specific fetal chromosomal aneuploidies. PerkinElmer shares closed up $1.34, or 4.06%, to $34.36.
News For PKI From The Last 14 Days
Check below for free stories on PKI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2014
11:32 EDTPKILabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use